Omeros OMER PDE7 — Total Costs & Expenses

Similar metrics at other companies

SLSTotal costs & expenses

$9.25M+52.6%

BHVNTotal costs & expenses

$130.43M-41.1%

AGIOTotal costs & expenses

$130.77M+13.4%

CRNXTotal costs & expenses

$151.11M+35.2%

GERNTotal costs & expenses

$1.69M+40.3%

JANXTotal costs & expenses

$37.95M+8.7%

Questions, answered.

What is Omeros's PDE7 — total costs & expenses?

Omeros (OMER) reported PDE7 — total costs & expenses of $575K in Q4 2026.

How has Omeros's PDE7 — total costs & expenses changed year-over-year?

Omeros's PDE7 — total costs & expenses increased by 4.5% year-over-year, from $550K to $575K.

What does PDE7 — total costs & expenses mean?

Captures the total operating costs directly attributable to the research, development, and administrative activities of the PDE7 product segment. This includes personnel costs, clinical trial expenses, and overhead allocated to advancing this specific therapeutic candidate. Monitoring this metric is essential for assessing the burn rate and capital efficiency of the company's individual pipeline programs.